Dr. Dennis Stephen Cesar, MD

Dr. Cesar practices at Merced Urology Medical Group, Inc. in Modesto, California.

Dr. Cesar's NPI, 1861685786, was assigned on August 23, 2007. Dr. Cesar graduated from Georgetown University School Of Medicine in 1972. Dr. Cesar holds California license G33716.

Dr. Cesar's primary practice is Merced Urology Medical Group, Inc., at 220 Standiford Ave, Modesto, CA 95350 in Stanislaus County. The practice phone is (209) 723-2122.

Dr. Cesar's primary practice is Merced Urology Medical Group, Inc. in Modesto, California. Dr. Cesar is also affiliated with Dignity Health - Mercy Medical Center. The medical group on file is Merced Urology Medical Group. Dmand AI also links Dr. Cesar to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cesar practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Cesar's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Cesar is board certified in urology by the American Board of Urology. Dr. Cesar is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Dr. Cesar treats.

CMS data shows 7,546 Medicare services from Dr. Cesar across 25 procedure codes in 2024, for 1,284 Medicare patients. Medicare paid $425,903 for them.

CMS counts 1,284 Medicare patients who saw Dr. Cesar in 2024. The largest group is 75 to 84, with 507 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cesar's median patient age at 69, with 29% women.

In 2024, Dr. Cesar wrote 6,115 Medicare Part D claims for 1,322 patients. 86% of them were for generic drugs. CMS names the drug for 5,984 of them, across 42 drugs with 11 or more claims each, at $1,320,863 in total drug cost. In 2023, CMS named 6,618 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Cesar for performance year 2024, reported as part of a group. Dr. Cesar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of prostate resection by Dr. Cesar, more than 93% of the clinicians it reports for that procedure.

CMS Open Payments shows 381 general payments to Dr. Cesar from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. Astellas Pharma US Inc paid the most, $5,323.

Dr. Cesar graduated from Georgetown University School Of Medicine in 1972.

Dr. Cesar is in network with 8 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.